• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Jan Geissler Explains Differing Perceptions for Living With CML

Video

Perceptions of chronic myelogenous leukemia (CML) and how to live with it are very different for patients and physicians, and a strong dialogue is needed to overcome the disparity, according to Jan Geissler, co-founder of the CML Advocates Network.

Perceptions of chronic myelogenous leukemia (CML) and how to live with it are very different for patients and physicians, and a strong dialogue is needed to overcome the disparity, according to Jan Geissler, co-founder of the CML Advocates Network.

At the 56th Annual Meeting of the American Society of Hematology in San Francisco, California, December 6-9, he discussed how there has been a lot of movement and a number of studies in the past years to help understand how CML patients perceive quality of life and severity of side effects.

“Especially in CML we’ve seen a lot of movement, because a very lethal disease, in the last 15 years, has turned into a chronic disease,” Mr Geissler said.

Related Videos
Frederick L Locke, MD, Moffitt
Pierluigi Porcu, MD
Cathy Eng, MD, FACP, FASCO, Vanderbilt-Ingram Cancer Center
Andrew Kuykendall, MD
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Andrew Kuykendall, MD, Moffitt Cancer Center
Ajai Chari, MD
Cathy Eng, MD, FACP, FASCO
Andrew Kuykendall, MD, Moffitt Cancer Center
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.